ArticleFrontiers in immunology2016

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.

Diego Sánchez-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.